HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in a ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced ...

HeartBeam (BEAT) announced that the FDA has granted 510(k) clearance for the company’s 12-lead electrocardiogram synthesis software for the ...

Santa Clara–based HeartBeam is developing a cable-free, credit-card-sized ECG recorder that captures 3D cardiac signals and synthesizes them into a diagnostic-quality 12-lead ECG. The platform’s ...

Beginning in February, Kern County will become the first in the state to equip all EMS providers with handheld, AI-enabled 12 ...

HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac ...

HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in a ...

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment ...